Climb Bio Inc.

NASDAQ:CLYM 4:00:00 PM EDT

1.24

+0.06 (+5.08%)

: $1.30 +0.06 (+4.84%)

Climb Bio Inc. Stock, NASDAQ:CLYM

20 William Street, Suite 145, Wellesley Hills, Massachusetts 02481-4103

United States of America

Phone: +1.866.857.2596

Number of Employees: 9

http://www.climbbio.com

Description

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.